CIA
TEVA icon

Cape Investment Advisory’s Teva Pharmaceuticals TEVA Stock Holding History

Cape Investment Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
+3,133
New +$104K 0.03% 334
2026
Q1 		– Sell
-3,088
Closed -$96.4K – 1100
2025
Q4 		$96.4K Buy
3,088
+2,412
+357% +$59.4K 0.03% 310
2025
Q3 		$13.7K Sell
676
-2,195
-76% -$38.6K 0.01% 361
2025
Q2 		$48.1K Buy
2,871
+137
+5% +$2.21K 0.02% 371
2025
Q1 		$42K Sell
2,734
-124
-4% -$2.21K 0.02% 359
2024
Q4 		$63K Hold
2,858
– – 0.02% 304
2024
Q3 		$51.5K Hold
2,858
– – 0.02% 317
2024
Q2 		$46.4K Hold
2,858
– – 0.02% 303
2024
Q1 		$40.3K Buy
2,858
+144
+5% +$1.81K 0.02% 336
2023
Q4 		$28.3K Hold
2,714
– – 0.01% 467
2023
Q3 		$27.7K Hold
2,714
– – 0.02% 389
2023
Q2 		$20.4K Buy
2,714
+102
+4% +$827 0.01% 432
2023
Q1 		$23.1K Buy
+2,612
New +$25.8K 0.01% 399

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Cape Investment Advisory's TEVA Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 3,133 shares worth $106K. The stake represents 0.03% of the portfolio and ranks #334 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in TEVA as recently as Q4 2025.

Cape Investment Advisory first reported a position in TEVA in Q1 2023 and has held it in 13 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Cape Investment Advisory held 3,133 shares of Teva Pharmaceuticals worth $106K as of Q2 2026.
  • Teva Pharmaceuticals was a new Cape Investment Advisory position in Q2 2026.
  • Teva Pharmaceuticals made up 0.03% of Cape Investment Advisory's portfolio in Q2 2026, its #334 holding.
  • Cape Investment Advisory first reported a position in Teva Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.